MCID: STR044
MIFTS: 33

Steroid-Resistant Nephrotic Syndrome malady

Categories: Genetic diseases (common), Nephrological diseases

Aliases & Classifications for Steroid-Resistant Nephrotic Syndrome

About this section

Aliases & Descriptions for Steroid-Resistant Nephrotic Syndrome:

Name: Steroid-Resistant Nephrotic Syndrome 22 65
Nephrotic Syndrome, Steroid-Resistant, Autosomal Recessive 65
 
Steroid Resistant Nephrotic Syndrome 22
Srn1 22

Classifications:



External Ids:

UMLS65 C0403397, C1868672

Summaries for Steroid-Resistant Nephrotic Syndrome

About this section
MalaCards based summary: Steroid-Resistant Nephrotic Syndrome, also known as nephrotic syndrome, steroid-resistant, autosomal recessive, is related to nephrotic syndrome, type 4 and chronic lymphocytic leukemia. An important gene associated with Steroid-Resistant Nephrotic Syndrome is NPHS2 (NPHS2 Podocin), and among its related pathways are Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers and Nephrin interactions. Affiliated tissues include breast, bone and liver, and related mouse phenotypes are renal/urinary system and mortality/aging.

Related Diseases for Steroid-Resistant Nephrotic Syndrome

About this section

Diseases related to Steroid-Resistant Nephrotic Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 239)
idRelated DiseaseScoreTop Affiliating Genes
1nephrotic syndrome, type 430.4CD2AP, NPHS1, WT1
2chronic lymphocytic leukemia30.2ALB, NPHS2
3sporadic idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis12.7
4familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis12.7
5familial steroid-resistant nephrotic syndrome with sensorineural deafness12.7
6sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation12.7
7sporadic idiopathic steroid-resistant nephrotic syndrome with minimal changes12.7
8sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis12.7
9familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis12.7
10familial idiopathic steroid-resistant nephrotic syndrome with minimal changes12.7
11familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation12.7
12sporadic idiopathic steroid-resistant nephrotic syndrome12.7
13sporadic idiopathic steroid-resistant nephrotic syndrome with collapsing glomerulopathy12.7
14nephrotic syndrome, type 212.0
15focal segmental glomerulosclerosis11.8
16nephrotic syndrome, idiopathic, steroid-resistant11.8
17coenzyme q10 deficiency, primary, 611.7
18nephrotic syndrome, type 110.7
19leukemia10.5
20lung cancer10.4
21thyroiditis10.4
22breast cancer10.4
23arthritis10.4
24lymphoma10.4
25endotheliitis10.4
26rheumatoid arthritis10.3
27medulloblastoma10.3
28systemic lupus erythematosus10.3
29cystic fibrosis10.3
30gastric cancer10.3
31blepharophimosis10.3
32sarcoma10.3
33diarrhea10.3
34prostatitis10.3
35melanoma10.3
36adenocarcinoma10.3
37pituitary adenoma10.3
38tuberculosis10.3
39adenoma10.3
40peritonitis10.3
41lymphosarcoma10.3
42myeloid leukemia10.3
43lupus erythematosus10.3
44meningitis10.3
45c1q deficiency10.1
46neuroblastoma10.1
47atopy10.1
48hiv-110.1
49hepatocellular carcinoma10.1
50asthma10.1

Graphical network of the top 20 diseases related to Steroid-Resistant Nephrotic Syndrome:



Diseases related to steroid-resistant nephrotic syndrome

Symptoms for Steroid-Resistant Nephrotic Syndrome

About this section

Drugs & Therapeutics for Steroid-Resistant Nephrotic Syndrome

About this section

Drugs for Steroid-Resistant Nephrotic Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
rituximabapprovedPhase 4, Phase 2, Phase 31582174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
2
Tacrolimusapproved, investigationalPhase 41023104987-11-3445643, 439492, 445647
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
8-DEETHYL-8-[but-3-enyl]-ascomycin
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
FR900506
 
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
Hecoria
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus Hydrate
Tacrolimus anhydrous
Tacrolimus hydrate
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
3AntibodiesPhase 44477
4Immunosuppressive AgentsPhase 410422
5Immunologic FactorsPhase 4, Phase 2, Phase 318483
6Antirheumatic AgentsPhase 4, Phase 2, Phase 38496
7Calcineurin InhibitorsPhase 41223
8ImmunoglobulinsPhase 44477
9
Irbesartanapproved, investigationalPhase 297138402-11-63749
Synonyms:
138402-11-6
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one
2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one
2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-[ p -( o -1 H -tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4,4]non-1-en-4-one
2-butyl-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[
2-butyl-3-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[
2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-n-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one
AC-537
AC1L1GMK
Aprovel
Avalide
Avapro
Avapro (TN)
BIDD:GT0347
BMS 186295
BMS Brand of Irbesartan
BMS-186295
BMS-186295, SR-47436, Aprovel, Karvea, Irbesartan
BRD-K60038276-001-02-5
BSPBio_002687
Bio-0053
Bristol Myers Brand of Irbesartan
C07469
C081309
C25H28N6O
CHEBI:5959
CHEMBL1513
CID3749
CPD000466306
D00523
DB01029
HMS1922J05
HMS2051L08
HMS2093E16
 
I06-0690
Irbesarran
Irbesartan
Irbesartan (JAN/USAN/INN)
Irbesartan [USAN:INN]
Irbesartan [Usan:Inn]
Irbetan
Jsp002315
KBio2_002231
KBio2_004799
KBio2_007367
KBio3_001907
KBioGR_001603
KBioSS_002231
Karvea
L000319
LS-60064
Lrbesartan
MLS000759408
MLS001424099
MolPort-003-666-550
NCGC00095122-01
NCGC00095122-02
NCGC00095122-03
S1507_Selleck
SAM001246548
SMR000466306
SPBio_001889
SPECTRUM1504259
SR 47436
SR-47436
STK645362
Sanofi Winthrop Brand of Irbesartan
Spectrum2_001675
Spectrum3_000994
Spectrum4_001122
Spectrum5_001288
Spectrum_001751
TL8000875
UNII-J0E2756Z7N
irbesartan
10AngiotensinogenPhase 21032
11Antihypertensive AgentsPhase 23618
12Angiotensin Receptor AntagonistsPhase 21039
13
Angiotensin IIPhase 2103368521-88-0, 11128-99-7172198, 65143
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
14Angiotensin II Type 1 Receptor BlockersPhase 2949
15
Cholecalciferolapproved, nutraceutical79967-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
16
Ergocalciferolapproved, nutraceutical92350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
17vitamin d1524
18Vitamins3857
19Trace Elements3900
20Micronutrients3901
21Bone Density Conservation Agents2600
22Ergocalciferols923
23Immunoglobulin A110
24Vitamin D2Nutraceutical923
25CalciferolNutraceutical1074

Interventional clinical trials:

idNameStatusNCT IDPhase
1Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic SyndromeRecruitingNCT02382575Phase 4
2Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in ChildrenWithdrawnNCT01162005Phase 4
3Rituximab Trial for Pediatric Nephrotic SyndromeRecruitingNCT01716442Phase 2, Phase 3
4Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental GlomerulosclerosisActive, not recruitingNCT01613118Phase 2
5Oral Galactose in Children With Steroid Resistant Nephrotic SyndromeCompletedNCT01113385
6Angiotensin Converting Enzyme Gene Polymorphism in Children With Idiopathic Nephrotic SyndromeCompletedNCT00172276
7Vitamin D Supplementation in Glomerular DiseaseRecruitingNCT01835639
8Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental GlomerulosclerosisTerminatedNCT00883636

Search NIH Clinical Center for Steroid-Resistant Nephrotic Syndrome

Genetic Tests for Steroid-Resistant Nephrotic Syndrome

About this section

Genetic tests related to Steroid-Resistant Nephrotic Syndrome:

id Genetic test Affiliating Genes
1 Steroid-Resistant Nephrotic Syndrome22 NPHS2

Anatomical Context for Steroid-Resistant Nephrotic Syndrome

About this section

MalaCards organs/tissues related to Steroid-Resistant Nephrotic Syndrome:

33
Breast, Bone, Liver, Heart, Lung, Endothelial, Spinal cord

Animal Models for Steroid-Resistant Nephrotic Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Steroid-Resistant Nephrotic Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053677.1ALB, CD2AP, MYO1E, NPHS1, NPHS2, WT1
2MP:00107687.1ALB, CD2AP, MYO1E, NPHS1, NPHS2, WT1
3MP:00053766.8ALB, CD2AP, MYO1E, NPHS1, NPHS2, WT1

Publications for Steroid-Resistant Nephrotic Syndrome

About this section

Articles related to Steroid-Resistant Nephrotic Syndrome:

(show top 50)    (show all 254)
idTitleAuthorsYear
1
Deletions of 5' HOXC genes are associated with lower extremity malformations, including clubfoot and vertical talus. (26729820)
2016
2
Giant saphenous vein graft pseudoaneurysm to right posterior descending artery presenting with superior vena cava syndrome. (26131340)
2015
3
Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. (24327013)
2014
4
Lymphomatoid papulosis as a harbinger of chronic lymphocytic leukemia. (24668491)
2014
5
Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate. (24734954)
2014
6
Complementary and alternative medicine use in patients with gout: a longitudinal observational study. (24356480)
2014
7
Axillary hidradenitis. (23359851)
2013
8
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies. (22712456)
2013
9
Electrophysiological mapping and radiofrequency catheter ablation for ventricular tachycardia in a patient with peripartum cardiomyopathy. (24102817)
2013
10
Skeletal tuberculosis presenting as a small cystic lesion in the medial femoral condyle. (25207301)
2013
11
Clinical answers: are nonpharmacological interventions for migraine effective in children and adolescents? (23877908)
2013
12
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients. (23280127)
2012
13
Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange. (22552883)
2012
14
Intradural chordoma of the Meckel's cave: a challenging differential diagnosis. (22260529)
2012
15
Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15. (21832070)
2011
16
Tear cytokines and chemokines in patients with Demodex blepharitis. (21050771)
2011
17
c-mip impairs podocyte proximal signaling and induces heavy proteinuria. (20484117)
2010
18
Influence of common and specific HLA-DRB1/DQB1 haplotypes on genetic susceptibilities of three distinct Arab populations to type 1 diabetes. (19005023)
2009
19
Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. (19001191)
2009
20
WAVE2 is regulated by multiple phosphorylation events within its VCA domain. (19012317)
2009
21
Antigen levels of urokinase-type plasminogen activator receptor and its gene polymorphism related to microvessel density in colorectal cancer. (18511987)
2008
22
A patient with bronchiectasis presented with progressive dyspnoea and an unresolved right lower lung infiltrate. (18820116)
2008
23
Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population. (19018234)
2008
24
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. (17898099)
2007
25
Repression of p53-mediated transcription by adenovirus E1B 55-kDa does not require corepressor mSin3A and histone deacetylases. (17209038)
2007
26
Molecular typing of Treponema pallidum strains from patients with neurosyphilis in Pretoria, South Africa. (17244664)
2007
27
Two variants of MutS homolog hMSH5: prevalence in humans and effects on protein interaction. (15907804)
2005
28
Identification of cytochrome P450 enzymes in human colorectal metastases and the surrounding liver: a proteomic approach. (15341988)
2004
29
Spectral analyses of sleep EEG in depressed offspring of fathers with or without a positive history of alcohol abuse or dependence: a pilot study. (13679113)
2003
30
Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. (12812761)
2003
31
IL-4 expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure. (12835549)
2003
32
Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. (12825758)
2003
33
Advances in the therapy of von Willebrand disease. (12010427)
2002
34
Myxoid leiomyosarcoma of the uterus. Report of a case with cytologic findings. (10834002)
2000
35
Decreased amplitude of left ventricular posterior wall motion with notch movement to determine the left posterior septal accessory pathway in Wolff-Parkinson-White syndrome. (10573503)
1999
36
Oral psoralen-UV-A for systemic scleroderma. (10328211)
1999
37
CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease. (9823960)
1998
38
Risperidone-induced galactorrhea associated with a prolactin elevation. (9622047)
1998
39
An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. (9699523)
1998
40
Treatment of idiopathic retroperitoneal fibrosis with tamoxifen. (9394333)
1997
41
Crosslinking of SRF to the c-fos SRE CArG box guanines using photo-active thioguanine oligodeoxynucleotides. (8954101)
1996
42
Foodborne botulism--Oklahoma, 1994. (7885310)
1995
43
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. (7797077)
1995
44
Increased frequency of mutations in the hprt gene of T cells isolated from patients with anti-U1-70kD-autoantibody-positive connective tissue disease. (7920025)
1994
45
Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer. (7691145)
1993
46
CSF-1 (colony stimulating factors 1) and CSF-1 receptor. General review and expression in invasive breast tumors]. (8204917)
1993
47
Expression of proliferation-associated antigens in cutaneous lymphoid infiltrates]. (2395218)
1990
48
Lymphopenia and abnormal lymphocyte subsets in the "BB" rat: relationship to the diabetic syndrome. (6978807)
1982
49
Low renin hypertension. (1096763)
1975
50

Variations for Steroid-Resistant Nephrotic Syndrome

About this section

Expression for genes affiliated with Steroid-Resistant Nephrotic Syndrome

About this section
Search GEO for disease gene expression data for Steroid-Resistant Nephrotic Syndrome.

Pathways for genes affiliated with Steroid-Resistant Nephrotic Syndrome

About this section

Pathways related to Steroid-Resistant Nephrotic Syndrome according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.4ALB, WT1
29.1CD2AP, NPHS1
38.7CD2AP, NPHS1, NPHS2

GO Terms for genes affiliated with Steroid-Resistant Nephrotic Syndrome

About this section

Cellular components related to Steroid-Resistant Nephrotic Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulumGO:00057839.3ALB, NPHS2
2cell-cell junctionGO:00059119.2CD2AP, NPHS2
3protein complexGO:00432348.9CD2AP, NPHS2

Sources for Steroid-Resistant Nephrotic Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet